Tern PLC Capital Markets Day Webinar Recording available

Synetics Plc

Tern Plc (LON:TERN), the AIM quoted investment company specialising in the Internet of Things (“IoT”) market, announced today that a recording of the investor webinar held on 14th September 2021 and featuring presentations by Tern’s portfolio companies, Device Authority and FundamentalVR, together with a question and answer session, is available to view below.

Tern backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams. The company empower business owners to fulfill their potential for fast growth, market leadership and strong exit multiples.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines joins 2026 UK AI Index

Talking Medicines joins the UK AI Index 2026, confirming its growing role in data-driven healthcare strategy.

AI in Healthcare 2025

In 2025, AI began reshaping healthcare delivery and marketing with practical applications, signalling a maturing investment landscape.

Talking Medicines targets messaging risk in pharma brand strategy

Talking Medicines reduces messaging risk for pharma brands by measuring real-time HCP response.

Agentless security for untouchable IoT devices

Agentless IoT security provides identity‑driven protection for devices that cannot be directly managed, turning blind spots into governed assets.

Virtual reality surgical training wins industry attention with scalable model

A new VR training solution backed by Orbis and Fundamental XR is gaining global traction by tackling real-world gaps in surgical education.

Tern Plc publishes presentations from Device Authority and Talking Medicines investor event

Tern Plc has released copies of the presentations delivered by portfolio companies Device Authority and Talking Medicines during its recent online investor presentation and Q&A session.

Search

Search